ATP and Cancer Immunosurveillance

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2021 Jun 14

PMID 34121201

Citations 87

Authors

Oliver Kepp

Lucillia Bezu

Takahiro Yamazaki

Francesco Di Virgilio

Mark J Smyth

Guido Kroemer

Lorenzo Galluzzi

Affiliations

Soon will be listed here.

Abstract

While intracellular adenosine triphosphate (ATP) occupies a key position in the bioenergetic metabolism of all the cellular compartments that form the tumor microenvironment (TME), extracellular ATP operates as a potent signal transducer. The net effects of purinergic signaling on the biology of the TME depend not only on the specific receptors and cell types involved, but also on the activation status of cis- and trans-regulatory circuitries. As an additional layer of complexity, extracellular ATP is rapidly catabolized by ectonucleotidases, culminating in the accumulation of metabolites that mediate distinct biological effects. Here, we discuss the molecular and cellular mechanisms through which ATP and its degradation products influence cancer immunosurveillance, with a focus on therapeutically targetable circuitries.

Citing Articles

Immunogenic cell death signature predicts survival and reveals the role of VEGFA + Mast cells in lung adenocarcinoma.

Zhang M, Zhou G, Xu Y, Wei B, Liu Q, Zhang G Sci Rep. 2025; 15(1):7213.

PMID: 40021802 PMC: 11871002. DOI: 10.1038/s41598-025-91401-5.

Differential cell architecture and microenvironmental responses of pretumoral and tumoral cellular models exposed to coverslip-induced hypoxia.

Millan M, Parietti F, Lamela F, De Rossi M, Benitez B, Levi V Histochem Cell Biol. 2025; 163(1):23.

PMID: 39751684 DOI: 10.1007/s00418-024-02350-5.

Role of P2X7 receptor in the progression and clinicopathological characteristics of gastric cancer.

Zhang W, Pi X, Le Y, Li T Sci Rep. 2024; 14(1):31673.

PMID: 39738256 PMC: 11685580. DOI: 10.1038/s41598-024-81515-7.

Scutellaria barbata D.Don and Hedyotis diffusa Willd herb pair combined with cisplatin synergistically inhibits ovarian cancer progression through modulating oxidative stress via NRF2-FTH1 autophagic degradation pathway.

Sui X, Gao B, Zhang L, Wang Y, Ma J, Wu X J Ovarian Res. 2024; 17(1):246.

PMID: 39702302 PMC: 11658162. DOI: 10.1186/s13048-024-01570-6.

Immunogenic cell death: A new strategy to enhancing cancer immunotherapy.

Dou L, Fang Y, Yang H, Ai G, Shen N Hum Vaccin Immunother. 2024; 20(1):2437918.

PMID: 39655738 PMC: 11639453. DOI: 10.1080/21645515.2024.2437918.

References

Li J, Wang L, Chen X, Li L, Li Y, Ping Y . CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer. Oncoimmunology. 2017; 6(6):e1320011. PMC: 5486179. DOI: 10.1080/2162402X.2017.1320011. View

Bidula S, Dhuna K, Helliwell R, Stokes L . Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages. Cell Death Dis. 2019; 10(12):882. PMC: 6877589. DOI: 10.1038/s41419-019-2110-3. View

Jiang L, Huang S, Li W, Zhang D, Zhang S, Zhang W . Expression of autophagy and ER stress-related proteins in primary salivary adenoid cystic carcinoma. Pathol Res Pract. 2012; 208(11):635-41. DOI: 10.1016/j.prp.2012.07.008. View

Medina C, Mehrotra P, Arandjelovic S, Perry J, Guo Y, Morioka S . Metabolites released from apoptotic cells act as tissue messengers. Nature. 2020; 580(7801):130-135. PMC: 7217709. DOI: 10.1038/s41586-020-2121-3. View

Saez J, Contreras-Duarte S, Gomez G, Labra V, Santibanez C, Gajardo-Gomez R . Connexin 43 Hemichannel Activity Promoted by Pro-Inflammatory Cytokines and High Glucose Alters Endothelial Cell Function. Front Immunol. 2018; 9:1899. PMC: 6104120. DOI: 10.3389/fimmu.2018.01899. View

Galluzzi L, Humeau J, Buque A, Zitvogel L, Kroemer G . Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nat Rev Clin Oncol. 2020; 17(12):725-741. DOI: 10.1038/s41571-020-0413-z. View

Chang C, Qiu J, OSullivan D, Buck M, Noguchi T, Curtis J . Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell. 2015; 162(6):1229-41. PMC: 4864363. DOI: 10.1016/j.cell.2015.08.016. View

Beavis P, Henderson M, Giuffrida L, Mills J, Sek K, Cross R . Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy. J Clin Invest. 2017; 127(3):929-941. PMC: 5330718. DOI: 10.1172/JCI89455. View

Wang X, Zhang T, Song Z, Li L, Zhang X, Liu J . Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome. Int J Cancer. 2019; 145(5):1414-1422. DOI: 10.1002/ijc.32144. View

10.

DAlmeida S, Kauffenstein G, Roy C, Basset L, Papargyris L, Henrion D . The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27. Oncoimmunology. 2016; 5(7):e1178025. PMC: 5006905. DOI: 10.1080/2162402X.2016.1178025. View

11.

Wennerberg E, Spada S, Rudqvist N, Lhuillier C, Gruber S, Chen Q . CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection. Cancer Immunol Res. 2020; 8(4):465-478. PMC: 7125001. DOI: 10.1158/2326-6066.CIR-19-0449. View

12.

Mora-Garcia M, Lopez-Cisneros S, Gutierrez-Serrano V, Garcia-Rocha R, Weiss-Steider B, Hernandez-Montes J . HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1. Mediators Inflamm. 2019; 2019:4651627. PMC: 6530152. DOI: 10.1155/2019/4651627. View

13.

Gaertner F, Massberg S . Patrolling the vascular borders: platelets in immunity to infection and cancer. Nat Rev Immunol. 2019; 19(12):747-760. DOI: 10.1038/s41577-019-0202-z. View

14.

Wu J, Wang Y, Xu W, Luo W, Wan F, Zhang H . High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma. Onco Targets Ther. 2020; 13:10453-10464. PMC: 7569176. DOI: 10.2147/OTT.S272553. View

15.

Kayhan M, Koyas A, Akdemir I, Savas A, Cekic C . Adenosine Receptor Signaling Targets Both PKA and Epac Pathways to Polarize Dendritic Cells to a Suppressive Phenotype. J Immunol. 2019; 203(12):3247-3255. DOI: 10.4049/jimmunol.1900765. View

16.

Pietrocola F, Pol J, Vacchelli E, Rao S, Enot D, Baracco E . Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell. 2016; 30(1):147-160. PMC: 5715805. DOI: 10.1016/j.ccell.2016.05.016. View

17.

Shi L, Feng M, Du S, Wei X, Song H, Yixin X . Adenosine Generated by Regulatory T Cells Induces CD8 T Cell Exhaustion in Gastric Cancer through A2aR Pathway. Biomed Res Int. 2020; 2019:4093214. PMC: 6942766. DOI: 10.1155/2019/4093214. View

18.

Vitale I, Shema E, Loi S, Galluzzi L . Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat Med. 2021; 27(2):212-224. DOI: 10.1038/s41591-021-01233-9. View

19.

Sprooten J, Agostinis P, Garg A . Type I interferons and dendritic cells in cancer immunotherapy. Int Rev Cell Mol Biol. 2019; 348:217-262. DOI: 10.1016/bs.ircmb.2019.06.001. View

20.

Allard B, Cousineau I, Allard D, Buisseret L, Pommey S, Chrobak P . Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis. Oncoimmunology. 2019; 8(8):1601481. PMC: 6682371. DOI: 10.1080/2162402X.2019.1601481. View